Airflow limitation in smokers is associated with subclinical atherosclerosis. - Wikidata - awgldk - TriplyDB

Airflow limitation in smokers is associated with subclinical atherosclerosis.

Airflow limitation in smokers is associated with subclinical atherosclerosis.

http://www.wikidata.org/entity/Q46309534

about

Cross-sectional and prospective study of the association between lung function and prediabetes Epicardial adipose tissue in patients with chronic obstructive pulmonary disease.Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD.Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis.A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: Prospective hospital-based case control study.C-reactive protein levels, airflow obstruction, and chronic kidney disease Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.Retrospective analysis of the relationship between decline in FEV(1) and abdominal circumference in male smokers: the Takahata study.Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study.Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study.The association between COPD and heart failure risk: a review Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins.Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease.Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease Heart-lung interaction via infection Update in chronic obstructive pulmonary disease 2009.Association between carotid intima-media thickness and presence of coronary artery disease in chronic obstructive pulmonary disease patients.Role of endothelin receptor A and NADPH oxidase in vascular abnormalities.Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.Current best practice in pulmonary rehabilitation for chronic obstructive pulmonary disease.Should mild COPD be treated? Evidence for early pharmacological intervention.The role of microparticles in chronic obstructive pulmonary disease Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease.Subclinical Carotid Atherosclerosis in COPD Cases and Control Smokers: Analysis in Relation with COPD Exacerbations and Exacerbation-like Episodes.Lung Function Abnormalities in Smokers with Ischemic Heart Disease.Subclinical carotid atherosclerosis in patients with chronic obstructive pulmonary disease: a meta-analysis of literature studies.Mild chronic obstructive pulmonary disease: why spirometry is not sufficient!Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress.Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study.Relation between respiratory function and arterial stiffness assessed using brachial-ankle pulse wave velocity in healthy workers.Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study.Defining COPD-Related Comorbidities, 2004-2014.Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro.Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease.

P2860

Q28395087-9772BD46-B8A2-46D8-B651-17A58050FC46 Q31119379-F3EE5A26-F2C9-48D9-9DC9-3A5D126E8C85 Q33703730-2779D762-9B76-41CF-B7D1-ECCACC58C687 Q34053824-5D633408-AC3D-487E-B01E-B4D7D11C366F Q34309085-C4DF9A68-A08D-4D7A-9047-34ABD7AF19D5 Q34425006-109F9A9A-8C1D-4009-8A93-D1B037033DB8 Q35071075-81D7EE23-4BD2-43ED-A714-5B2CA970CBA1 Q35215089-2EA7FC3D-5A79-4BC6-9411-AB3E35AC42B9 Q35672663-A1AFF76F-7E45-4146-B5DF-8A27CAED446D Q35980048-BB1D17C9-6731-4D28-B8DA-9C549403CA35 Q36045565-21B464BE-062E-45F8-BAE1-B89A09644433 Q36501493-EB66E873-71BC-4E62-A1F8-E96050CA51D1 Q36741308-EF76D215-8089-4D7A-A92A-EC3F09071508 Q36822495-BE769F8B-CDF4-4921-9A80-8A92C9C0C92D Q36980625-5B4E1F8C-CB54-40F1-AB28-7CFE89CF5040 Q37007407-3F30FB3F-1DA1-4E4C-8F71-8258D832BE56 Q37352193-602E930C-6E2F-4FDD-AC04-2A2E0E263077 Q37485173-93B15490-3C9A-4749-869C-DA3F19A1718C Q37573101-C190A702-0693-45D1-BECA-EA6F7FECCB88 Q37673443-9035B1C4-7E1A-4750-9861-3A7BB35BFF0F Q37679759-AB60D058-1861-4C6B-BFB6-FEE0CA7E0C5C Q37718404-D6F83EA5-543A-4FDD-8D75-CE3B8B51E8B7 Q37723864-8D7F4429-5F74-423F-97F2-AFAAEE286AC2 Q37790995-EAEA781B-FCA2-4295-BFBE-69BBE7B7B0F2 Q37940008-47271437-E7DE-4619-B6C3-B7D0F20BB9FA Q38007926-EEBCECE6-49D0-4518-95D4-10C4A70963D6 Q38161458-3B4151CB-2AD6-49BF-95C5-2896221F187C Q38202635-F9424B25-C49C-44B7-9296-E822023A4553 Q38588362-BFAF32DC-E4B0-43EE-96D2-DA92DE7B238A Q38753446-29512592-8B87-4945-9289-5F46D6A2E03D Q38839263-58526384-120E-44DF-818E-D789649E6D7F Q38888060-D7105C56-2F24-4A8E-A3D0-954C79BE51CA Q39332602-2BE38FAB-5EE3-4EE5-A3D4-216D375037C9 Q40383327-4C026A65-D0AC-44BB-B20F-33A545727A66 Q40623148-56F794EF-102D-447F-AEC6-4AF0CBE9741F Q41038503-2D296423-CF2B-4359-BE4D-3A1947677612 Q41297968-3DA60B99-6904-46B6-A562-90CBB802EF21 Q41443181-225A3A6D-F9F2-477B-9395-FA951A211585 Q42268357-2E60D3EB-C3F9-4408-8A68-0AF1B8B47217 Q43014156-40654B4F-2951-4DF7-886B-18EB3C7765C6

P2860

Airflow limitation in smokers is associated with subclinical atherosclerosis.

http://www.wikidata.org/entity/Q46309534

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Airflow limitation in smokers is associated with subclinical atherosclerosis.

@en

Airflow limitation in smokers is associated with subclinical atherosclerosis.

@nl

type

label

Airflow limitation in smokers is associated with subclinical atherosclerosis.

@en

Airflow limitation in smokers is associated with subclinical atherosclerosis.

@nl

prefLabel

Airflow limitation in smokers is associated with subclinical atherosclerosis.

@en

Airflow limitation in smokers is associated with subclinical atherosclerosis.

@nl

P1433

Q46309534-D15819A1-B2A9-4E94-83F9-9482C1C868DF

P1476

Q46309534-DFC2924D-84BF-4B7A-9801-F82F2B6CA1C5

P2093

Q46309534-24545194-29D5-4602-AD53-3ADA0206D68E

Q46309534-401EE80D-460D-44D5-B942-67BAB5EDD17B

Q46309534-4DF9A119-3973-490B-A777-FA6D8C33BC71

Q46309534-AB599160-88AF-4FA0-B97D-41FD6F400080

Q46309534-D3FD6D1E-715F-4749-87D2-1063679EA452

Q46309534-DE1742CF-763B-4511-B1AE-E9BB74D31DEE

Q46309534-E5EA9233-2308-45C0-859D-B4D833A1A91A

Q46309534-F038CD4D-BBAB-441A-9E9D-7E1483F6D880

P2860

Q46309534-04A1D437-E036-4120-8AFB-CBB4DBF4411B

Q46309534-06E383F4-97BD-4AA8-9D82-A76F7BA4CF6B

Q46309534-0E032FDB-6D53-4482-B347-BE70340E70B8

Q46309534-53139C21-0FF7-431D-8DD9-91B521107755

Q46309534-5A7EC3DD-5309-4799-8909-33E67B5F2886

Q46309534-5E94C677-3A82-44F8-B7B7-103D9EC2DAB4

Q46309534-64AC51DA-4CC9-4A6D-AF30-CEEA2D5206BB

Q46309534-75EB69BC-CDD1-43E1-8E15-CAD48904D876

Q46309534-783AC312-6F64-48EA-A96F-DD2DDCEF0567

Q46309534-8DD5F7B1-5A12-442F-8877-DC68CFD6A36D

P304

Q46309534-25D184D5-3D10-4223-8880-5DE7B71519AB

P31

Q46309534-24C867EF-2B33-4472-8365-7F5859876A1D

P356

Q46309534-2C9599DA-52DB-4BF7-9876-F9BB7FCB9BB8

P407

Q46309534-E2B45AF9-97A9-4FC7-8A49-CE718652D7DE

P433

Q46309534-2CAC164F-75E7-4A2A-BC06-AFE0BBDBEC78

P478

Q46309534-2082AADE-6C3C-4DEF-991C-BA46EF3A2E4A

P50

Q46309534-52EA8A7F-4547-4734-8D8C-A0DB77965BFB

P577

Q46309534-5FE05C2B-C449-49D9-98AA-DBBA78A4B4C7

P698

Q46309534-858D8075-29EB-491A-A37E-EF7FAB261484

P921

Q46309534-1906B962-CCCF-458F-A4A0-A2D0956F5F0E

P356

RCCM.200804-560OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Airflow limitation in smokers is associated with subclinical atherosclerosis

@en

P2093

Akihito Yokoyama

http://www.w3.org/2001/XMLSchema#string

Hitoshi Hara

http://www.w3.org/2001/XMLSchema#string

Kiminori Yamane

http://www.w3.org/2001/XMLSchema#string

Noboru Hattori

http://www.w3.org/2001/XMLSchema#string

Nobuhisa Ishikawa

http://www.w3.org/2001/XMLSchema#string

Nobuoki Kohno

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Kitahara

http://www.w3.org/2001/XMLSchema#string

Yoshinori Haruta

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Standardization of Spirometry, 1994 Update. American Thoracic Society

The pathogenesis of atherosclerosis: a perspective for the 1990s

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: longitudinal and cross-sectional results from 'Men born in 1914', Sweden.

Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease.

Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology.

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.

P304

35-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200804-560OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Hiroshi Iwamoto

P577

2008-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18931335

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis